Health Condition 1: null- High Risk Patients for ERCP
Conditions
Interventions
Intervention1: pancreatic duct stent: 5F 3 cm
single pigtail
At time of ERCP
Control Intervention1: diclofenac sodium suppository: 100mg
single dose
rectal suppository
Immediately after ERCP
Sponsors
Sheri Kashmir Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.Young age less than 60 years, 2.Female gender, 3.Suspected sphincter of Oddi dysfunction, 4.Recurrent pancreatitis, 5.Prior history of post ERCP pancreatitis, 6.Patients with normal serum bilirubin. 7. Multiple pancreatic duct injections 8.Difficult or failed cannulation 9.Pancreatic sphincterotomy, 10.Precut access, and 11.Balloon dilation.
Exclusion criteria
Exclusion criteria: Patients with pancreatic duct stricture in the head of the pancreas, Those who have undergone previous endoscopic papillectomy, Those who have undergone previous endoscopic sphincterotomy (ES), Those with an indwelling nasobilliary or nasopancreatic tube , Those with acute pancreatitis. Children less than 18 years of age. Those with contra-indications to NSAIDS. Low-risk patients (older, obstructed pancreatic duct).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prevention of morbidity and mortality related to Post-ERCP pancreatitisTimepoint: 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| hospital stay and costTimepoint: 2 weeks | — |
Countries
India
Contacts
Public Contactdr mohd yasin mujoo
Sheri Kashmir Institute Of Medical Sciences
Outcome results
None listed